marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2022-Q2
added 08-15-2022
La Jolla Pharmaceutical Company Financial Statements 2011-2024 | LJPC
Annual Financial Statements La Jolla Pharmaceutical Company
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
110 M | 167 M | 185 M | 144 M | 707 M | 330 M | 277 M | 233 M | 3.86 M | 918 K | - |
Shares |
27.4 M | 27.3 M | 27.1 M | 25.4 M | 21.2 M | 17.2 M | 15.7 M | 10.7 M | 454 K | 204 K | - |
Historical Prices |
4.63 | 6.12 | 6.85 | 6.04 | 34.3 | 19.4 | 17.7 | 21.8 | 8.45 | 5 | - |
Net Income |
19.7 M | -39.4 M | -117 M | -199 M | -115 M | -78.2 M | -41.9 M | -21.3 M | -17.9 M | -7.74 M | -11.5 M |
Revenue |
75.7 M | 33.4 M | 23.1 M | 10.1 M | - | 616 K | 1.06 M | - | - | - | - |
Cost of Revenue |
- | 7.82 M | 2.39 M | 1.64 M | - | - | - | - | - | - | - |
Gross Profit |
- | 25.6 M | 20.7 M | 8.41 M | - | - | - | - | - | - | - |
Operating Income |
21.8 M | -35.8 M | -110 M | -194 M | -115 M | -78.4 M | -42 M | -21.3 M | -17.9 M | -10.7 M | -2.27 M |
Interest Expense |
733 K | -46 K | -6.71 M | 7.3 M | - | - | 57 K | 27 K | 6 K | 4 K | 234 K |
EBITDA |
21.9 M | -31.8 M | -105 M | -190 M | -114 M | -77.6 M | -41.6 M | -21.3 M | -17.9 M | -13.7 M | 7 M |
Operating Expenses |
- | 61.4 M | 130 M | 202 M | 115 M | 79 M | 43 M | 21.3 M | 17.9 M | 10.7 M | 2.27 M |
General and Administrative Expenses |
35.4 M | 34.5 M | 37.9 M | 61.2 M | 30.9 M | 16.7 M | 13.9 M | 11.4 M | 13.6 M | 9.39 M | - |
All numbers in USD currency
Quarterly Income Statement La Jolla Pharmaceutical Company
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
- | - | 25.3 M | 26.2 M | 26.8 M | 27.5 M | 27.5 M | 27.4 M | 27.4 M | 27.4 M | 27.3 M | 27.2 M | 27.2 M | 27.1 M | 27.1 M | 27 M | 26.3 M | 26.2 M | 26.2 M | 22.7 M | 22.2 M | 22.1 M | 22.1 M | 18.4 M | 17.3 M | 17.2 M | 17.2 M | 17.2 M | 17.2 M | 14.9 M | 15.3 M | 15.2 M | 15.2 M | 13.6 M | 8.12 M | 5.54 M | 4.4 M | 827 K | 550 K | 17.5 M | 285 K | 13.3 M | 11.6 M | 2.09 M | 875 K | 533 K | 12.4 M | 947 K |
Net Income |
- | - | 2.46 M | 2 K | - | -2.26 M | 3.73 M | 14.4 M | - | -11.8 M | -15.6 M | -8.59 M | - | -29.2 M | -30.4 M | -31.7 M | - | -50.7 M | -52.8 M | -50.5 M | -38.5 M | -26.3 M | -26.7 M | -23.2 M | -24.9 M | -21.3 M | -15.6 M | -16.5 M | -11.8 M | -10.5 M | -10.6 M | -8.96 M | -6.85 M | -5.05 M | -4.28 M | -5.13 M | - | -4.17 M | -3.16 M | -4.2 M | - | -2.22 M | -7.7 M | 5.28 M | - | 3.57 M | 4.71 M | -6.51 M |
Revenue |
- | - | 10.5 M | 10.4 M | - | 13.3 M | 16.1 M | 34.1 M | - | 9.07 M | 5.8 M | 7.59 M | - | 5.71 M | 5.7 M | 4.4 M | - | 3.47 M | 1.59 M | 809 K | - | - | - | - | 85 K | 44 K | 253 K | 234 K | 410 K | 647 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | 2.49 M | 808 K | 716 K | - | 554 K | 551 K | 500 K | - | 256 K | 129 K | 58 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
- | - | -1.07 M | -2.05 M | - | 525 K | 3.79 M | 17.5 M | - | -9.53 M | -12.5 M | -10.5 M | - | -26.8 M | -28.2 M | -29.7 M | - | -48.4 M | -51.6 M | -50.7 M | -38.8 M | -26.5 M | -26.8 M | -23.3 M | -24.9 M | -21.3 M | -15.6 M | -16.5 M | -11.9 M | -10.5 M | -10.7 M | -8.97 M | -6.86 M | -5.06 M | -4.29 M | -5.13 M | - | -4.17 M | -3.16 M | -4.2 M | - | -3.45 M | -3.21 M | -671 K | - | -423 K | -904 K | -478 K |
Interest Expense |
- | - | -489 K | 543 K | - | -25 K | 80 K | -448 K | - | 281 K | -693 K | 1.87 M | - | -2.36 M | - | -2.02 M | - | -2.38 M | -1.21 M | 166 K | - | 195 K | 101 K | 28 K | - | 46 K | 51 K | 53 K | - | 13 K | 8 K | 11 K | - | 9 K | 2 K | 2 K | - | 1 K | 1 K | 1 K | - | -1 K | 1 K | 1 K | - | 234 K | 236 K | -2 K |
EBITDA |
- | - | -1.02 M | -2.02 M | - | 925 K | 3.85 M | 17.5 M | - | -7.37 M | -10.7 M | -9.4 M | - | -23.4 M | -26 M | -28.5 M | - | -45.1 M | -49.5 M | -49.7 M | -38.8 M | -25.6 M | -26.2 M | -23 M | -24.9 M | -20.8 M | -15.3 M | -16.4 M | -11.9 M | -10.4 M | -10.6 M | -8.96 M | -6.86 M | -5.06 M | -4.28 M | -5.13 M | - | -4.17 M | -3.16 M | -4.2 M | - | -3.45 M | -3.21 M | -671 K | - | -423 K | -904 K | -478 K |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
- | - | 9.76 M | 10.3 M | - | 8.63 M | 9 M | 8.76 M | - | 12.5 M | 8.68 M | 8.15 M | - | 10.8 M | 11.3 M | 12.3 M | - | 21.1 M | 22.2 M | 23 M | - | 7.39 M | 6.02 M | 5.5 M | - | 4.35 M | 3.47 M | 4.05 M | - | 3.35 M | 3.97 M | 3.8 M | - | 2.44 M | 2.69 M | 3.13 M | - | 3.22 M | 2.46 M | 3.55 M | - | 2.97 M | 2.88 M | 637 K | - | 423 K | 727 K | 478 K |
All numbers in USD currency